| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| N-Nitroso Bilastine Impurity 7 |
N-亞硝基比拉斯汀雜質(zhì)7 |
|
詳細(xì)
|
| Sacubitril |
沙庫巴曲 |
149709-62-6 |
詳細(xì)
|
| Fidaxomicin-d7 |
|
|
詳細(xì)
|
| Propafenone N-Formyl Impurity |
|
|
詳細(xì)
|
| Tacrolimus Impurity 16-13C-d2 |
24,32-Bis-O-(tert-butyldimethylsilyl)-FK-506-13C, D2 (Major) |
1356352-20-9 |
詳細(xì)
|
| 2,9-Dinitroso Tadalafil Impurity 1 |
|
|
詳細(xì)
|
| (2S,3R,11bR)-Dihydrotetrabenazine-d6 |
2H6]-(+)-Β-二氫丁苯那嗪 |
1583277-32-0 |
詳細(xì)
|
| N-Nitroso Tadalafil |
N-亞硝基他達(dá)拉非 |
|
詳細(xì)
|
| Avibactam Impurity 7 |
阿維巴坦雜質(zhì) 9 |
|
詳細(xì)
|
| Tibolone Impurity 2 |
替勃龍雜質(zhì)2 |
1173998-66-7 |
詳細(xì)
|
| Terbutaline-d9 HCl |
特比萘芬-D9鹽酸 |
|
詳細(xì)
|
| Valsartan Impurity 5 |
纈沙坦雜質(zhì) 1 |
914465-68-2 |
詳細(xì)
|
| Valsartan Impurity 41 |
纈沙坦雜質(zhì)41 |
|
詳細(xì)
|
| Valsartan Impurity 47 |
纈沙坦雜質(zhì)47 |
|
詳細(xì)
|
| Apalutamide |
阿帕魯胺 |
956104-40-8 |
詳細(xì)
|
| (S)-Timolol-d9 Maleate |
(S)-TIMOLOL-D9馬來酸鹽 |
1286769-65-0 |
詳細(xì)
|
| Ibuprofen Ester Impurity (PEG400) |
Tetraethyleneglycol Bisibuprofen Ester |
1161014-75-0 |
詳細(xì)
|
| Donepezil Impurity 31 |
2,3-二氫-5,6-二甲氧基-2-[[1,2,3,4-四氫-1-芐基-4-吡啶基]亞甲基]-1H-茚-1-酮 |
1020661-51-1 |
詳細(xì)
|
| (3S,4R,5S)-Oseltamivir |
奧司他韋雜質(zhì)10 |
2081110-43-0 |
詳細(xì)
|
| Fesoterodine Impurity 5 Fumarate |
弗斯特羅定二醇二聚物 |
1428856-45-4 |
詳細(xì)
|
| 1,2-Diacetin |
3-羥基丙烷-1,2-二乙酸二酯 |
102-62-5 |
詳細(xì)
|
| Isoprenaline Impurity 2 |
1H-Indole-3,5,6-triol, 2,3-dihydro-1-(1-methylethyl)- (9CI) |
98496-30-1 |
詳細(xì)
|
| Isoproterenol Impurity 14 |
1H-Indole-3,5,6-triol,1-(1-methylethyl)-(9CI) |
73853-05-1 |
詳細(xì)
|
| Dexamethasone EP Impurity J (9-desfluoro-11-keto dexamethasone ) |
地塞米松EP雜質(zhì)J |
2036-77-3 |
詳細(xì)
|
| Potassium Clavulanate EP Impurity E Dipotassium Salt |
克拉維酸鹽EP雜質(zhì) |
1260617-10-4 |
詳細(xì)
|
| Potassium Clavulanate EP Impurity A |
克拉維酸鉀EP雜質(zhì)A |
4744-51-8 |
詳細(xì)
|
| Nicorandil Impurity 4 Dinitrate |
尼可地爾雜質(zhì)4 二硝酸鹽 |
|
詳細(xì)
|
| Chenodeoxycholic Acid (Ursodeoxycholic Acid EP Impurity A) |
鵝去氧膽酸 |
474-25-9 |
詳細(xì)
|
| (S)-2-methyl-4,5-dihydrothiazole-4-carboxylic acid |
|
190601-71-9 |
詳細(xì)
|
| Methyl Efavirenz |
RAC甲基依法韋侖 |
353270-76-5 |
詳細(xì)
|
| Everolimus Related Compound 5 |
依維莫司雜質(zhì)5 |
2607-52-5 |
詳細(xì)
|
| Sitagliptin Impurity 42 |
(2Z)-4-氧代-4-[3-(三氟甲基)-5,6-二氫-[1,2,4]三唑并[4,3-a]吡嗪-7-(8H)-基]-1-(2,4,5-三氟苯基)丁-2-酮 |
764667-65-4 |
詳細(xì)
|
| Rupatadine Impurity 6 HCl |
3-(氯甲基)-5-甲基吡啶鹽酸鹽 |
1007089-84-0 |
詳細(xì)
|
| Rupatadine EP Impurity C |
氯雷他定羥基哌N -氧化物 |
1224515-72-3 |
詳細(xì)
|
| Fidaxomicin Metabolite OP-1118 |
OP 1118 |
1030825-28-5 |
詳細(xì)
|
| Urea (Fluorouracil EP Impurity G) |
尿素 |
57-13-6 |
詳細(xì)
|
| 3-Butylphthalide |
丁苯酞 |
6066-49-5 |
詳細(xì)
|
| Tazobactam Acid Impurity 3 |
他唑巴坦酸雜質(zhì)3 |
|
詳細(xì)
|
| Budesonide EP Impurity J (Mixture of Diastereomers) |
布地奈德EP雜質(zhì)J |
313474-59-8 |
詳細(xì)
|
| Vitamin K1 Impurity 16 |
維生素K2雜質(zhì)05 |
110327-29-2 |
詳細(xì)
|
| Amlodipine Impurity 32 |
氨氯地平雜質(zhì)32 |
1621516-91-3 |
詳細(xì)
|
| Valsartan EP Impurity B (Valsartan USP Related Compound C) |
纈沙坦芐酯 |
137863-20-8 |
詳細(xì)
|
| Linagliptin-d3 |
利格列汀-D3 |
1398044-48-8 |
詳細(xì)
|
| Linagliptin-13C-d3 |
利那列汀-13C-D3 |
1398044-43-3 |
詳細(xì)
|
| Tazobactam Acid Impurity 41 |
他唑巴坦酸雜質(zhì)6 |
76911-24-5 |
詳細(xì)
|
| Acetylcysteine EP Impurity B (L-Cysteine) |
L-半胱氨酸 |
52-90-4 |
詳細(xì)
|
| Bilastine Impurity 15 |
比拉斯汀 |
1215537-40-8 |
詳細(xì)
|
| trans-Clevidipine Impurity 13 |
trans-Clevidipine Impurity 13 |
|
詳細(xì)
|
| Fosphenytoin Sodium-d10 |
苯妥英鈉D10 |
|
詳細(xì)
|
| cis-Clevidipine Impurity 13 |
cis-Clevidipine Impurity 13 |
|
詳細(xì)
|
| Iodixanol EP Impurity E |
碘克沙醇雜質(zhì) E |
255376-57-9 |
詳細(xì)
|
| Sulfasalazine-d4 |
柳氮磺胺吡啶-D4 |
1346606-50-5 |
詳細(xì)
|
| Arbidol Impurity 4 |
阿比朵爾雜質(zhì)4 |
|
詳細(xì)
|
| Ramelteon Metabolite M-II-d3 (Mixture of R and S at the Hydroxy Position) |
Ramelteon Metabolite M-II-d3 (mixture of R and S at the hydroxy position) |
1246812-22-5 |
詳細(xì)
|
| Ramelteon-d5 |
雷美替胺-D5 |
1134159-63-9 |
詳細(xì)
|
| Cefuroxime-d3 |
JFPVXVDWJQMJEE-QDGUUNGESA-N |
1803240-98-3 |
詳細(xì)
|
| Phenytoin-d10 |
苯妥英D10 |
65854-97-9 |
詳細(xì)
|
| R-Amlodipine-d4 |
(R)-氨氯地平-D4 |
1346616-97-4 |
詳細(xì)
|
| Methylprednisolone Impurity 9 |
甲基潑尼松龍雜質(zhì)9 |
|
詳細(xì)
|
| Neomycin Sulfate EP Impurity A (Neamine) |
新霉胺 |
3947-65-7 |
詳細(xì)
|
| Piperaquine N,N-Dioxide |
哌喹代謝物5 |
925673-47-8 |
詳細(xì)
|
| Pregabalin EP Impurity A |
普瑞巴林EP雜質(zhì)A |
181289-23-6 |
詳細(xì)
|
| Amlodipine Impurity 18 |
氨氯地平雜質(zhì)L |
1821498-25-2 |
詳細(xì)
|
| Efavirenz Impurity 3 (Mixture of Z and E Isomers) |
EFAVIRENZ IMPURITY 3 (MIXTURE OF Z AND E ISOMERS) |
|
詳細(xì)
|
| Estriol EP Impurity F |
異雌三醇 |
547-81-9 |
詳細(xì)
|
| Bilastine Impurity 37 |
比拉斯汀雜質(zhì)37 |
2767508-99-4 |
詳細(xì)
|
| Epinastine Impurity 3 DiHCl |
依匹斯汀雜質(zhì)3 |
339163-80-3 |
詳細(xì)
|
| Prucalopride Hydroxy Impurity |
普盧卡必利羥基雜質(zhì) |
|
詳細(xì)
|
| Mitoxantrone EP impurity A |
米托蒽醌雜質(zhì)A |
89991-52-6 |
詳細(xì)
|
| Potassium Clavulanate EP Impurity D |
4-(2-羥乙基)-1H-吡咯-3-羧酸 |
404839-11-8 |
詳細(xì)
|
| Fusidic Acid |
夫西地酸 |
#6990-06-3 |
詳細(xì)
|
| Sarpogrelate Metabolite M1 HCl |
1-(二甲基氨基)-3-[2-[2-(3-甲氧基苯基)乙基]苯氧基]-2-丙醇鹽酸鹽 |
135261-74-4 |
詳細(xì)
|
| Sarpogrelate-d3 HCl |
鹽酸沙格雷酯 |
135159-51-2 |
詳細(xì)
|
| Bilastine Impurity 20 |
比拉斯汀中間體 |
361382-26-5 |
詳細(xì)
|
| Landiolol Impurity 5 |
蘭地洛爾雜質(zhì) |
190601-22-0 |
詳細(xì)
|
| Moxifloxacin-d4 HCl |
鹽酸莫西沙星D4 |
|
詳細(xì)
|
| Vildagliptin Impurity 28 |
1,3,5,7-四羥基金剛烷 |
16104-28-2 |
詳細(xì)
|
| Dapsone Impurity 13 |
4-[(4-Aminophenyl)sulfinyl]phenylamine |
119-59-5 |
詳細(xì)
|
| Ketorolac EP Impurity D |
酮咯酸雜質(zhì)D |
1391053-45-4 |
詳細(xì)
|
| Sulfadimethoxine EP Impurity C |
磺胺二甲氧嘧啶EP雜質(zhì)C |
121-62-0 |
詳細(xì)
|
| Acetyl Coenzyme A |
乙?；o酶A |
72-89-9 |
詳細(xì)
|
| Tazobactam Acid Impurity 21 |
他唑巴坦雙氧化物副產(chǎn)物 |
|
詳細(xì)
|
| N-Nitroso Chloropretadalafil |
|
|
詳細(xì)
|
| (2R,3R,11bR)-Dihydrotetrabenazine-d6 |
2H6]-(+)-Α-二氫丁苯那嗪 |
1583277-30-8 |
詳細(xì)
|
| Daprodustat-d8 |
|
2250290-94-7 |
詳細(xì)
|
| Roxadustat Impurity 3 |
羅沙司他光解雜質(zhì) |
2301113-15-3 |
詳細(xì)
|
| Amlodipine Impurity 35 |
氨氯地平雜質(zhì)35 |
|
詳細(xì)
|
| Astragalus Metabolite 4 |
2'-羥基芒柄花黃素 |
1890-99-9 |
詳細(xì)
|
| Landiolol Impurity 16 |
艾司洛爾雜質(zhì)18 |
1582797-17-8 |
詳細(xì)
|
| N-Nitroso Aripiprazole |
|
|
詳細(xì)
|
| Landiolol Impurity 12 |
Landiolol |
944919-03-3 |
詳細(xì)
|
| Potassium Clavulanate EP Impurity B Sodium Salt |
|
|
詳細(xì)
|
| Estriol EP Impurity E |
17-環(huán)雌三醇 |
1228-72-4 |
詳細(xì)
|
| Glycerophosphorylethanolamine |
2-胺乙基-2,3-二羥丙基-羥基磷酸酯 |
1190-00-7 |
詳細(xì)
|
| Amlodipine Impurity 69 |
氨氯地平雜質(zhì)69 |
|
詳細(xì)
|
| Tenofovir Impurity 126 |
替諾福韋雜質(zhì)126 |
2241284-68-2 |
詳細(xì)
|
| Cefdinir Impurity 1 Sodium salt |
頭孢地尼雜質(zhì)1鈉鹽 |
66436-47-3 |
詳細(xì)
|
| Oxytocin Impurity 14 (Carbamido-Oxytocin) |
|
|
詳細(xì)
|
| Lamivudine Impurity 18 |
拉米夫定雜質(zhì)15 |
1904611-15-9 |
詳細(xì)
|
| Spilanthol |
花菊素 |
25394-57-4 |
詳細(xì)
|